z-logo
open-access-imgOpen Access
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
Author(s) -
Anna Lidofsky,
Jacinta A. Holmes,
Eoin R. Feeney,
Annie J. Kruger,
Shadi Salloum,
Hui Zheng,
Isabel S Seguin,
Akif Altınbaş,
Ricard Masia,
Kathleen E. Corey,
Jenna Gustafson,
Esperance Schaefer,
Peter W. Hunt,
Steven G. Deeks,
Ma Somsouk,
Kara W. Chew,
Raymond T. Chung,
Nadia Alatrakchi
Publication year - 2018
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiy331
Subject(s) - coinfection , virology , hepatitis c virus , virus , immunology , biology , medicine
Coinfection with human immunodeficiency virus (HIV) accelerates hepatitis C virus (HCV)-related liver fibrosis. Macrophages are triggered during both viral infections and are critical in liver inflammation/fibrogenesis. Liver fibrosis strongly associates with serum soluble CD163 (sCD163, a macrophage activation marker); comprehensive evaluation in HIV/HCV coinfection is lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom